bioMérieux
A global leader in in vitro diagnostics for clinical and industrial applications.
BIM | PA
Overview
Corporate Details
- ISIN(s):
- FR0013280286 (+13 more)
- LEI:
- 549300AK8Y0LBIQ4T071
- Country:
- France
- Address:
- 376 CHE DE L'ORME, 69280 MARCY-L'ETOILE
- Website:
- https://www.biomerieux.com/
- Sector:
- Manufacturing
Description
bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2021-09-02 10:45 |
Rapport Financier Semestriel
|
French | PDF • 3.1 MB | ||
| 2021-08-12 18:09 |
Juillet 2021 - Déclaration sur le nombre d'actions composant le capital social …
|
French | PDF • 205.5 KB | ||
| 2021-07-07 14:53 |
Bilan semestriel du contrat de liquidité BIOMERIEUX
|
French | PDF • 391.0 KB | ||
| 2021-07-07 13:54 |
bioMérieux S.A - Juin 2021 - Déclaration sur le nombre d'actions composant le c…
|
French | PDF • 204.9 KB | ||
| 2021-06-29 18:28 |
In the fight against Antimicrobial Resistance, bioMérieux and Specific Diagnost…
|
English | PDF • 439.0 KB | ||
| 2021-06-29 18:28 |
Lutte contre l'antibiorésistance : bioMérieux et Specific Diagnostics annoncent…
|
French | PDF • 443.3 KB | ||
| 2021-06-24 07:05 |
bioMérieux launches EPISEQ® SARS-COV-2, a cloud-based software application for …
|
English | PDF • 408.6 KB | ||
| 2021-06-24 07:05 |
bioMérieux lance EPISEQ® SARS-COV-2, une application logicielle sur le cloud po…
|
French | PDF • 390.9 KB | ||
| 2021-06-10 16:54 |
Mai 2021 - Déclaration capital et droits de vote
|
French | PDF • 205.5 KB | ||
| 2021-05-20 16:15 |
AG 2021 - Descriptif du programme de rachat d'actions
|
French | PDF • 227.7 KB | ||
| 2021-05-20 16:15 |
AG 2021 - Descriptif du programme de rachat d'actions
|
English | PDF • 144.0 KB | ||
| 2021-05-10 07:01 |
bioMérieux announces the CE marking of the new generation semi-quantitative VID…
|
English | PDF • 423.8 KB | ||
| 2021-05-10 07:01 |
bioMérieux annonce le marquage CE de la nouvelle génération de test sérologique…
|
French | PDF • 392.9 KB | ||
| 2021-05-05 16:58 |
Avril 2021 - Déclaration sur le nombre d'actions composant le capital social et…
|
French | PDF • 206.2 KB | ||
| 2021-04-30 07:01 |
bioMérieux announces CE-marking of the new MALDI-TOF mass spectrometry identifi…
|
English | PDF • 107.6 KB |
Automate Your Workflow. Get a real-time feed of all bioMérieux filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for bioMérieux
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for bioMérieux via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-04 | N/A | Other | Sell | 1,432 | 137,517.82 EUR |
| 2023-09-04 | N/A | Other | Sell | 1,253 | 120,328.10 EUR |
| 2023-09-01 | N/A | Other | Other | 2,900 | N/A |
| 2023-06-23 | N/A | Other | Other | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 300 | 23,193.00 EUR |
| 2023-06-23 | N/A | Other | Buy | 25 | 1,932.75 EUR |
| 2023-03-23 | N/A | Other | Sell | 16,500 | 1,650,415.80 EUR |
Peer Companies
